End of Ozempic patent could reduce price by up to 35%, says laboratory wanting to make generic
The expiration of the semaglutide patent in March is expected to lead to a price reduction of up to 35% for Ozempic, according to pharmaceutical company EMS, which is interested in producing a generic version.
This stock will rise to ₹22,500, currently at half the price... Brokerage says - Buy
The brokerage Motilal Oswal Financial Services recommends investing in EMS companies, predicting significant growth driven by government initiatives and increasing manufacturing capacity.
What should be the weight of long sets?
The Polish Chamber of Freight Forwarding and Logistics argues for a minimum allowable total weight of 48 tons for EMS class sets during and after the pilot phase, similar to the adopted Czech formula, although a higher limit is preferred.